Lv21
170 积分 2024-06-22 加入
Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes-Randomized Controlled Trial (PRISM-RCT) in Chinese patients with young-onset diabetes: design, methods and baseline characteristics
2个月前
已完结
The HASTER lncRNA promoter is a cis-acting transcriptional stabilizer of HNF1A
4个月前
已完结
A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12)
4个月前
已完结
<p>Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment</p>
4个月前
已完结
Application of CRISPR‐Cas9 technology in diabetes research
4个月前
已完结
Meglitinide Analogues in Adolescent Patients With HNF1A-MODY (MODY 3)
4个月前
已完结
Three years of liraglutide treatment offers continuously optimal glycemic control in a pediatric patient with maturity-onset diabetes of the young type 3
4个月前
已完结
Mody-3: Novel HNF1A Mutation and the Utility of Glucagon-Like Peptide (GLP)-1 Receptor Agonist Therapy
4个月前
已完结
Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats
4个月前
已完结
A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin‐treated patients
4个月前
已完结
皖公网安备34019202002308
